NCT05839561View on ClinicalTrials.gov

Monotherapy With Letrozole in Tubal Pregnancy

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

December 30, 2022

Study Completion Date

June 30, 2023

Conditions
Tubal Pregnancy Unruptured
Interventions
DRUG

Letrozole as monotherapy

Letrozole 5 mg daily orally for 10 days from day 0

DRUG

MTX as monotherapy

MTX in a single dose of 100 mg intravenously on day 0

Trial Locations (1)

31-501

Jagiellonian University Medical College, Department of Gynecology and Obstetrics, Clinic of Gynecological Endocrinology, Krakow

All Listed Sponsors
lead

Jagiellonian University

OTHER

NCT05839561 - Monotherapy With Letrozole in Tubal Pregnancy | Biotech Hunter | Biotech Hunter